Laddar...
Estrogen receptor degradation: a CUE for endocrine resistance?
Despite the undoubted success of adjuvant endocrine therapies that target the estrogen receptor pathway, not all women with estrogen receptor-positive breast cancer respond to these therapies, and many who initially respond will subsequently relapse. Deregulation of various aspects of estrogen recep...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3236333/ https://ncbi.nlm.nih.gov/pubmed/21861853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2914 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|